Case Report: Successful treatment of recurrent COVID-19 with intravenous immunoglobulin in a patient with rituximab-induced B-cell depletion and restoration of Fc-mediated effector functions

We report the case of a 47-year-old woman with neuromyelitis optica spectrum disorder who developed prolonged coronavirus disease 2019 (COVID-19) pneumonia 3 months after receiving rituximab. Rituximab-induced B-cell depletion left her highly susceptible to persistent viral infection, resulting in t...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Hee Bum Jo, Jong Su Kang, Sungim Choi, Seong Yeon Park
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	Frontiers Media S.A. 2026-05-01
Saila:	Frontiers in Immunology
Gaiak:	B-cell depletion COVID-19 Fc effector function intravenous immunoglobulin rituximab
Sarrera elektronikoa:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1797070/full
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!